Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2026-01-22 @ 12:49 PM
Study NCT ID:
NCT01477333
Status:
COMPLETED
Last Update Posted:
2023-12-27
First Post:
2011-11-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
Sponsor:
United Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TDE-PH-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None